Phase Ii Data For The Met Inhibitor Tepotinib In Patients With Advanced Nsclc And Met Exon 14-Skipping Mutations
JOURNAL OF THORACIC ONCOLOGY（2018）
关键词
tepotinib,MET inhibitor,non-small cell lung cancer
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要